Archive for the ‘Latest News’

Migraine Nurse Phone Line

Migraine
15th August 2018

Phone access to the Migraine Nurse is now only through the MAI Information and Support Line. If you need to contact her please contact us here on 1850 200 378 or email us at info@migraine.ie and we can help put you in... [read more]


CGRP Update!! All your questions answered.

1st August 2018

CGRP Update Following member’s queries and questions around the introduction of this new drug and in response to the large volume of online comments and questions, (read our original press release here) The Migraine Association sought clarification on a number of issues with Novartis who have confirmed the following: Erenumab is the first and only treatment specifically designed for migraine prevention to be approved in the European... [read more]


Migraine Information for non-English Speakers

19th June 2018

Migraine is a disorder that affects all levels of society, gender, age, socio-economic status and nationality. Ireland has grown into a wonderfully diverse country with people from all over the world living, working, bringing their culture here, and unfortunately suffering from migraine too! It can be hard for non- English speakers to access relevant health information in Ireland and in recognition of that information gap, we have translated... [read more]


Cluster Headache: Fostering Empathy through Patients’ own Stories

20th April 2018

If you want to understand what it really means to live with cluster headache, imagine... fostering empathy through European patients’ own stories of their experiences Cluster headache (CH) is regarded as the most severe pain known to mankind. The severity of the pain has earned it the nickname “suicide headache”. Unfortunately there is a lack of empathy for people who suffer from CH and this affects how they are treated by friends,... [read more]


New Drugs for Migraine on the Way

6th December 2017

Calcitonin gene-related receptor (CGRP) antagonists are the most important medications in advanced stage clinical development for the treatment of both the acute migraine attack and the prevention of frequent attacks. Clinical trials on two of the antibodies have now been published in the New England Journal of Medicine. One antibody, Erenumab made by Novartis, was trialed on 955 patients with episodic migraine. At the start of the... [read more]


Archive for the ‘Latest News’

Migraine Nurse Phone Line

Migraine
15th August 2018

Phone access to the Migraine Nurse is now only through the MAI Information and Support Line. If you need to contact her please contact us here on 1850 200 378 or email us at info@migraine.ie and we can help put you in... [read more]


CGRP Update!! All your questions answered.

1st August 2018

CGRP Update Following member’s queries and questions around the introduction of this new drug and in response to the large volume of online comments and questions, (read our original press release here) The Migraine Association sought clarification on a number of issues with Novartis who have confirmed the following: Erenumab is the first and only treatment specifically designed for migraine prevention to be approved in the European... [read more]


Migraine Information for non-English Speakers

19th June 2018

Migraine is a disorder that affects all levels of society, gender, age, socio-economic status and nationality. Ireland has grown into a wonderfully diverse country with people from all over the world living, working, bringing their culture here, and unfortunately suffering from migraine too! It can be hard for non- English speakers to access relevant health information in Ireland and in recognition of that information gap, we have translated... [read more]


Cluster Headache: Fostering Empathy through Patients’ own Stories

20th April 2018

If you want to understand what it really means to live with cluster headache, imagine... fostering empathy through European patients’ own stories of their experiences Cluster headache (CH) is regarded as the most severe pain known to mankind. The severity of the pain has earned it the nickname “suicide headache”. Unfortunately there is a lack of empathy for people who suffer from CH and this affects how they are treated by friends,... [read more]


New Drugs for Migraine on the Way

6th December 2017

Calcitonin gene-related receptor (CGRP) antagonists are the most important medications in advanced stage clinical development for the treatment of both the acute migraine attack and the prevention of frequent attacks. Clinical trials on two of the antibodies have now been published in the New England Journal of Medicine. One antibody, Erenumab made by Novartis, was trialed on 955 patients with episodic migraine. At the start of the... [read more]